A Tokyo-based healthtech startup Ubie, has secured US$18.7 million in its series B funding round led by Suzuken, a Japanese pharmaceutical distributor. The company raised the funding of US$10.1 million in its previous funding rounds.
Moreover, the conversation around brain fog has prompted a call for greater
Ambien Next Day Delivery awareness and education in both clinical settings and the general public. In our fast-paced lives, we often
Lyrica Overnight Shipping overlook the importance of sleep, and even more so, the impact that stressors can have on our ability to achieve restorative rest. It’s crucial to
Buy Xanax Without Rx highlight that the journey
How To Buy Xanax Online through chronic illness and mental health issues is highly individual. Furthermore,
Tramadol Online ongoing research into novel interventions, such as mobile health solutions that provide real-time support for those trying to quit smoking,
Xanax Without Prescription has gained traction. Understanding these interconnected issues can provide valuable insights into managing anxiety and reducing the risk of developing problematic behaviors. Clinical guidelines are also shifting to include pharmacists more prominently
Tramadol Online Purchase in the management of chronic conditions. This reaction is often linked to the fear of judgment from peers and educators, the pressure to achieve high grades,
Order Xanax No Prescription and the perceived importance of the outcome
Ambien Cheap for future opportunities. Additionally, public health initiatives aimed at promoting
Zolpidem Overnight Shipping emotional well-being can play
Order Xanax No Prescription a significant role in fostering healthier populations. In this context, understanding the spasmolytic
Buy Zopiclone 7.5 Mg Online effect
Order Valium Without Prescription of certain medications can play a critical role in managing symptoms for those experiencing muscle spasms.
The company would utilize the new funds to expand its research and development capabilities, hire new talent for sales and engineering roles, and scale its products.
Related – Japanese startup PlayBrain secures $6M in Series A led by Bitkraft
The company was founded by Yoshinori Abe and Kota Kubo in the year 2017, operates AI Monshin, a saas product for hospitals, and an AI symptom checker app for individual users.
AI Monshin automatically asks medically relevant questions customized for every patient. It combines workflow-enhancing functions with clinical decision support to make medical record keeping more efficient. The company claims it can help diagnose 1,104 diseases and reduce interview time by around six minutes.
Meanwhile, its AI symptom checker could help users understand their symptoms better by answering questions from within an app. The startup officially released the service in April in response to the Covid-19 pandemic.
According to a report, last year, the Asian health tech sector saw nearly US$5 billion in total funding across 340 deals . China, India, and South Korea were the top three markets in terms of total deal value. Meanwhile, investments in Southeast Asia doubled to US$266 million.
